Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Eskelinen

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|July 1, 1992
Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic valueP K Lipponen, M J Eskelinen
Anticancer Research|March 1, 1992
Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological descriptionP K Lipponen, M J Eskelinen
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancerP K Lipponen, M J Eskelinen
The European Journal of Surgery = Acta Chirurgica|June 12, 1999
Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methodsM J Eskelinen, U H Haglund
Anticancer Research|January 1, 1991
Nucleolar organiser regions (NORs) in bladder cancer; relation to histological grade, clinical stage and prognosisP K Lipponen, M J Eskelinen
Anticancer Research|March 1, 1991
How to count mitoses in bladder cancer grading?P K Lipponen, M J Eskelinen
European Urology|January 1, 1990
Volume-corrected mitotic index and mitotic activity index in transitional cell bladder cancerP K Lipponen, M J Eskelinen
The Journal of Pathology|August 1, 1994
Expression of pS2 protein in transitional cell bladder tumoursP K Lipponen, M J Eskelinen
Oncology|January 1, 1992
Argyrophilic nucleolar organiser regions in transitional cell bladder tumours related to established prognostic factors, progression and independent prognostic valueP K Lipponen, M J Eskelinen
British Journal of Urology|February 1, 1993
Expression of C-50 antigen as a prognostic variable in transitional cell bladder tumoursP K Lipponen, M J Eskelinen
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|July 1, 1992
Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic valueP K Lipponen, M J Eskelinen
Anticancer Research|March 1, 1992
Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological descriptionP K Lipponen, M J Eskelinen
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancerP K Lipponen, M J Eskelinen
The European Journal of Surgery = Acta Chirurgica|June 12, 1999
Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methodsM J Eskelinen, U H Haglund
Anticancer Research|January 1, 1991
Nucleolar organiser regions (NORs) in bladder cancer; relation to histological grade, clinical stage and prognosisP K Lipponen, M J Eskelinen
Anticancer Research|March 1, 1991
How to count mitoses in bladder cancer grading?P K Lipponen, M J Eskelinen
European Urology|January 1, 1990
Volume-corrected mitotic index and mitotic activity index in transitional cell bladder cancerP K Lipponen, M J Eskelinen
The Journal of Pathology|August 1, 1994
Expression of pS2 protein in transitional cell bladder tumoursP K Lipponen, M J Eskelinen
Oncology|January 1, 1992
Argyrophilic nucleolar organiser regions in transitional cell bladder tumours related to established prognostic factors, progression and independent prognostic valueP K Lipponen, M J Eskelinen
British Journal of Urology|February 1, 1993
Expression of C-50 antigen as a prognostic variable in transitional cell bladder tumoursP K Lipponen, M J Eskelinen
Pageof 6